ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.17 HKD | 0.00% |
|
-3.35% | -25.24% |
| Apr. 03 | Alibaba Health Refutes Rumors of Purchase of Telemedicine Platform HaoDF | MT |
| Mar. 28 | Alibaba Health Information Technology Limited and Alibaba.com Enter Shared Services Agreement | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 28.51B 3.95B 30.83B | Sales 2025 * | 33.31B 4.61B 36.03B | Capitalization | 47.14B 6.53B 50.98B |
|---|---|---|---|---|---|
| Net income 2024 * | 766M 106M 828M | Net income 2025 * | 1.14B 158M 1.23B | EV / Sales 2024 * | 1.27 x |
| Net cash position 2024 * | 10.91B 1.51B 11.8B | Net cash position 2025 * | 12.46B 1.72B 13.47B | EV / Sales 2025 * | 1.04 x |
| P/E ratio 2024 * |
55.4
x | P/E ratio 2025 * |
36.4
x | Employees | 1,547 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.22% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 week | -3.35% | ||
| Current month | +7.09% | ||
| 1 month | +9.69% | ||
| 3 months | +0.96% | ||
| 6 months | -33.82% | ||
| Current year | -25.24% |
1 week
2.98
3.31
1 month
2.593.43
Current year
2.594.30
1 year
2.595.82
3 years
2.5923.25
5 years
2.5930.15
10 years
2.5930.15
| Managers | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 46 | - |
Yan Wu Tu
DFI | Director of Finance/CFO | 46 | 19-08-31 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yi Hong Wu
BRD | Director/Board Member | 56 | 23-08-10 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
Rong Shao
BRD | Director/Board Member | 62 | 23-08-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.59% | 0 M€ | +13.30% | - | |
| 1.56% | 0 M€ | +16.09% | - | |
| 1.56% | 0 M€ | +14.93% | - | |
| 1.42% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 3.17 | 0.00% | 44,077,550 |
| 24-05-09 | 3.17 | +3.59% | 60,638,310 |
| 24-05-08 | 3.06 | +0.33% | 58,943,130 |
| 24-05-07 | 3.05 | -4.09% | 87,933,510 |
| 24-05-06 | 3.18 | -3.05% | 87,632,620 |
Delayed Quote Hong Kong S.E., May 10, 2024 at 04:08 am EDT
More quotes
Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities:
- direct sale of pharmaceuticals (85.2%);
- online sale of pharmaceuticals(12.7%);
- direct healthcare services (1.8%);
- online healthcare services and monitoring of pharmaceuticals (0.3%).
The turnover is divided into the revenue sources of product sales (80.8%) and services (19.2%).
The geographical breakdown of the turnover is as follows: mainland China (95.8%) and Hong Kong (4.2%).
Sector
Drug Retailers
Calendar
2024-05-22
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
2.931
CNY
Average target price
5.094
CNY
Spread / Average Target
+73.78%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -25.24% | 6.52B | |
| -34.16% | 14.83B | |
| -24.55% | 12.04B | |
| +14.96% | 6.44B | |
| -8.01% | 6.15B | |
| -2.34% | 4.64B | |
| +60.00% | 4.62B | |
| -8.10% | 3.93B | |
| -11.16% | 3.49B | |
| -6.77% | 3.05B |
- Stock Market
- Equities
- 241 Stock
